1-chloro-8-broMooctane

We are 1-chloro-8-broMooctane CAS:28598-82-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-chloro-8-broMooctane
CAS.NO:28598-82-5
Synonyms:1-chloro-8-broMooctane
1-bromo-8-chloro-octane
8-bromo-1-chlorooctane
1-chloro-8-bromo-octane
1-bromo-8-chlorooctane
Molecular Formula:C8H16BrCl
Molecular Weight:227.57000
 
Physical and Chemical Properties:
Density:1.2
Melting point:ºC
Boiling point:264.8ºC
Flash point:143.3ºC
Index of Refraction:1.470
 
Specification:
Appearance:Colorless or pale yellow transparent liquid
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

1-chloro-8-broMooctane


Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry.2',3',5'-Tri-O-acetyl-D-adenosine Pharmaceutical intermediates and APIs belong to the fine chemical industry.Ácido bifenil-3-borónico CAS:5122-95-2 Pharmaceutical intermediates and APIs belong to the fine chemical industry.401564-36-1 This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?

Related Products
Product Name
5,6-Dibromopyridine-3-carboxylic acid View Details
GLYCERYL CAPRYLATE Cas:26402-26-6 View Details
BENZYL MERCAPTAN Cas:100-53-8 View Details
hydrogenated tallowamine  Cas:61788-45-2 manufacturer 1,3-dibutyl-2-thiourea Cas:109-46-6 manufacturer 2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one Cas:1013916-37-4 manufacturer Flame Retardant HPCTP manufacturer 4-Fluorobenzoylacetonitrile Cas:NO: 4640-67-9 manufacturer